Suchergebnisse - "Janardanan Subramonia Kumar"

Prevalence of Hepatic Steatosis and Fibrosis in Asian Indian Individuals with Type 2 Diabetes.

Autoren: Bhuvanesswar, Khandhulwa Chandramouli Srivastava, Brijendra Kumar Amutha, Anandakumar et al.

Quelle: Diabetes Therapy; Sep2025, Vol. 16 Issue 9, p1797-1811, 15p

Schlagwörter: FATTY liver, FIBROSIS, PUBLIC health, METABOLIC disorders, TYPE 2 diabetes, INDIANS (Asians), ELASTOGRAPHY, NON-alcoholic fatty liver disease

Imeglimin-based therapies improve glycemic control and reduce mitochondrial stress in type 2 diabetes: a prospective cohort study.

Autoren: Satheesan, Abhishek Kumar, Janardanan Subramonia Vajravelu, Leela Kakithakara et al.

Quelle: Frontiers in Endocrinology; 2025, p1-13, 13p

Schlagwörter: GLYCEMIC control, TYPE 2 diabetes, HYPOGLYCEMIC agents, CLINICAL trials, MITOCHONDRIAL pathology, ANTI-inflammatory agents, TREATMENT effectiveness

Effect of SGLT2 Inhibitors on Renal Resistive Index in Diabetic Nephropathy Patients: A Quasi-experimental Study.

Autoren: CHANDNI JAYAKUMAR SRITHEJA GOPALAKRISHNAN SUSHMITHA KANNAN et al.

Quelle: Journal of Clinical & Diagnostic Research; Jan2026, Vol. 20 Issue 1, p19-24, 6p

To compare the HOMA-IR and metabolic profile in lean and obese subjects with non-alcoholic fatty liver disease.

Autoren: Nair, Meenu C. Stanley, Lanord Sivan, Gisha et al.

Quelle: Egyptian Liver Journal; 5/29/2024, Vol. 14 Issue 1, p1-6, 6p

Schlagwörter: NON-alcoholic fatty liver disease, FATTY liver, METABOLIC syndrome, DISEASE prevalence, INSULIN resistance, OBESITY

Effect of ranolazine as add-on therapy in type 2 diabetic dyslipidaemia patients: A randomised open-label trial.

Autoren: Ravula, Sahithya Ravali Karunanidhi Santhana, Lakshmi Thangavel Mahalingam, Vijayakumar et al.

Quelle: International Journal of Clinical Practice; Apr2021, Vol. 75 Issue 4, p1-2, 2p